435 related articles for article (PubMed ID: 33927214)
1. Alantolactone inhibits cervical cancer progression by downregulating BMI1.
Sun X; Xu H; Dai T; Xie L; Zhao Q; Hao X; Sun Y; Wang X; Jiang N; Sang M
Sci Rep; 2021 Apr; 11(1):9251. PubMed ID: 33927214
[TBL] [Abstract][Full Text] [Related]
2. Aberrantly elevated Bmi1 promotes cervical cancer tumorigenicity and tumor sphere formation via enhanced transcriptional regulation of Sox2 genes.
Xu R; Chen L; Yang WT
Oncol Rep; 2019 Aug; 42(2):688-696. PubMed ID: 31173263
[TBL] [Abstract][Full Text] [Related]
3. Alantolactone exhibits selective antitumor effects in HELA human cervical cancer cells by inhibiting cell migration and invasion, G2/M cell cycle arrest, mitochondrial mediated apoptosis and targeting Nf-kB signalling pathway.
Zhang Y; Zhao Y; Ran Y; Guo J; Cui H; Liu S
J BUON; 2019; 24(6):2310-2315. PubMed ID: 31983099
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol suppresses the growth and metastatic potential of cervical cancer by inhibiting STAT3
Sun X; Xu Q; Zeng L; Xie L; Zhao Q; Xu H; Wang X; Jiang N; Fu P; Sang M
Cancer Med; 2020 Nov; 9(22):8685-8700. PubMed ID: 33040485
[TBL] [Abstract][Full Text] [Related]
5. BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor.
Yu J; Chen L; Bao Z; Liu Y; Liu G; Li F; Li L
Oncol Rep; 2020 May; 43(5):1630-1640. PubMed ID: 32323819
[TBL] [Abstract][Full Text] [Related]
6. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.
Chun J; Li RJ; Cheng MS; Kim YS
Cancer Lett; 2015 Feb; 357(1):393-403. PubMed ID: 25434800
[TBL] [Abstract][Full Text] [Related]
7. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
[TBL] [Abstract][Full Text] [Related]
9. Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling.
Zheng H; Yang L; Kang Y; Chen M; Lin S; Xiang Y; Li C; Dai X; Huang X; Liang G; Zhao C
Mol Carcinog; 2019 Apr; 58(4):565-576. PubMed ID: 30520143
[TBL] [Abstract][Full Text] [Related]
10. Knockdown BMI1 expression inhibits proliferation and invasion in human bladder cancer T24 cells.
Liang W; Zhu D; Cui X; Su J; Liu H; Han J; Zhao F; Xie W
Mol Cell Biochem; 2013 Oct; 382(1-2):283-91. PubMed ID: 23820733
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Growth of Esophageal Cancer by Alantolactone via Wnt/β- Catenin Signaling.
Wang Z; Hu Q; Chen H; Shi L; He M; Liu H; Li T; Lü M; Deng M; Luo G
Anticancer Agents Med Chem; 2021; 21(18):2525-2535. PubMed ID: 33438562
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion.
Xia C; He Z; Cai Y
Cell Mol Biol Lett; 2020; 25():25. PubMed ID: 32265995
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
[TBL] [Abstract][Full Text] [Related]
14. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
15. PTC209, a Specific Inhibitor of BMI1, Promotes Cell Cycle Arrest and Apoptosis in Cervical Cancer Cell Lines.
Li J; Vangundy Z; Poi M
Anticancer Res; 2020 Jan; 40(1):133-141. PubMed ID: 31892561
[TBL] [Abstract][Full Text] [Related]
16. Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma.
Proctor E; Waghray M; Lee CJ; Heidt DG; Yalamanchili M; Li C; Bednar F; Simeone DM
PLoS One; 2013; 8(2):e55820. PubMed ID: 23437065
[TBL] [Abstract][Full Text] [Related]
17. Alantolactone exhibits antiproliferative and apoptosis-promoting properties in colon cancer model via activation of the MAPK-JNK/c-Jun signaling pathway.
Ren Y; Lv C; Zhang J; Zhang B; Yue B; Luo X; Yu Z; Wang H; Ren J; Wang Z; Dou W
Mol Cell Biochem; 2021 Dec; 476(12):4387-4403. PubMed ID: 34460036
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines.
Deng B; Zhang S; Miao Y; Zhang Y; Wen F; Guo K
Med Oncol; 2015 Apr; 32(4):102. PubMed ID: 25740178
[TBL] [Abstract][Full Text] [Related]
19. ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer.
Wei XL; Dou XW; Bai JW; Luo XR; Qiu SQ; Xi DD; Huang WH; Du CW; Man K; Zhang GJ
Oncotarget; 2015 Aug; 6(25):21704-17. PubMed ID: 26023734
[TBL] [Abstract][Full Text] [Related]
20. Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo.
Liu N; Ma M; Qu N; Wang R; Chen H; Hu F; Gao S; Shan F
Int Immunopharmacol; 2020 Sep; 86():106718. PubMed ID: 32585612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
